Thomas E. Hogan - 02 Jul 2026 Form 4 Insider Report for Cellebrite DI Ltd. (CLBT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CLBT
Reported as of: 02 Jul 2026
Net transaction value: -$1,625,892
SEC form: 4
Accepted by SEC: 07 Jul 2026, 07:29:43 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas E. Hogan

Key filing fact

Thomas E. Hogan filed Form 4 for Cellebrite DI Ltd. (CLBT) on 07 Jul 2026.

Key facts

This page summarizes Thomas E. Hogan's Form 4 filing for Cellebrite DI Ltd. (CLBT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 07:29.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$1,625,892.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013619 Primary reporting owner

Hogan Thomas E.

Relationship: Chief Executive Officer, Director
Address: 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature: /s/ Thomas E. Hogan
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT transaction

Ordinary shares, par value NIS 0.00001

Sale

Transaction value: $1,625,892
Shares: -103,188
Change %: -15%
Price: $15.76
Shares after: 590,777
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.